Manja Friese-Hamim

This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 7 CIPO patents and 7 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manja Friese-Hamim. Retrieved from https://idiyas.com/inventor/manja-friese-hamim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 6)

% Patents Active = 50.0

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

6 out of 3,021

Merck Patent Gmbh

patents

Years Active: 2016-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10532052 - Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor (2020-01-14),

2. 10231972 - Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a quinazoline derivative (2019-03-19),

3. 10093623 - Cyclic amides as MetAP-2 inhibitors (2018-10-09),

4. 10005756 - Pyrrolidinone derivatives as MetAP-2 inhibitors (2018-06-26),

5. 9809552 - Piperazine derivatives as FASN inhibitors (2017-11-07),

6. 9283225 - Pyrido-pyrimidine derivatives (2016-03-15),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.